Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis

Jennifer R. Zarcone, Steven E. Lindauer, Paige S. Morse, Kimberly A. Crosland, Maria G. Valdovinos, Todd L. McKerchar, R. Matthew Reese, Jessica A. Hellings, Stephen R. Schroeder

Research output: Research - peer-reviewArticle

Abstract

Functional analyses were conducted during a double-blind, placebo-controlled study of the atypical antipsychotic medication risperidone with 13 individuals. Risperidone was effective in reducing destructive behavior (compared to placebo) for 10 participants. For 7 of these responders, an undifferentiated pattern of responding occurred across their baseline functional analysis conditions (i.e., a similar rate of responding across conditions), and risperidone treatment produced nonspecific reductions of their destructive behavior across functional analysis conditions. For the remaining 3 responders, a differentiated pattern of responding occurred across their baseline functional analysis conditions (i.e., an elevated rate of responding occurred in a specific condition), and risperidone treatment produced function-specific reductions of their destructive behavior.

LanguageEnglish (US)
Pages310-321
Number of pages12
JournalAmerican Journal on Mental Retardation
Volume109
Issue number4
DOIs
StatePublished - Jul 2004

Fingerprint

Functional Analysis
Person
Developmental Disabilities
Risperidone
Disabled Persons
functional analysis
disability
human being
Placebo
Placebos
Therapeutics
Controlled
Medication
behavior analysis
medication
Antipsychotic Agents

ASJC Scopus subject areas

  • Rehabilitation
  • Health Professions(all)
  • Education

Cite this

Effects of risperidone on destructive behavior of persons with developmental disabilities : III. Functional analysis. / Zarcone, Jennifer R.; Lindauer, Steven E.; Morse, Paige S.; Crosland, Kimberly A.; Valdovinos, Maria G.; McKerchar, Todd L.; Reese, R. Matthew; Hellings, Jessica A.; Schroeder, Stephen R.

In: American Journal on Mental Retardation, Vol. 109, No. 4, 07.2004, p. 310-321.

Research output: Research - peer-reviewArticle

Zarcone, JR, Lindauer, SE, Morse, PS, Crosland, KA, Valdovinos, MG, McKerchar, TL, Reese, RM, Hellings, JA & Schroeder, SR 2004, 'Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis' American Journal on Mental Retardation, vol 109, no. 4, pp. 310-321. DOI: 10.1352/0895-8017(2004)109<310:EORODB>2.0.CO;2
Zarcone, Jennifer R. ; Lindauer, Steven E. ; Morse, Paige S. ; Crosland, Kimberly A. ; Valdovinos, Maria G. ; McKerchar, Todd L. ; Reese, R. Matthew ; Hellings, Jessica A. ; Schroeder, Stephen R./ Effects of risperidone on destructive behavior of persons with developmental disabilities : III. Functional analysis. In: American Journal on Mental Retardation. 2004 ; Vol. 109, No. 4. pp. 310-321
@article{11d7199c236b4ba7b5eea94eab885940,
title = "Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis",
abstract = "Functional analyses were conducted during a double-blind, placebo-controlled study of the atypical antipsychotic medication risperidone with 13 individuals. Risperidone was effective in reducing destructive behavior (compared to placebo) for 10 participants. For 7 of these responders, an undifferentiated pattern of responding occurred across their baseline functional analysis conditions (i.e., a similar rate of responding across conditions), and risperidone treatment produced nonspecific reductions of their destructive behavior across functional analysis conditions. For the remaining 3 responders, a differentiated pattern of responding occurred across their baseline functional analysis conditions (i.e., an elevated rate of responding occurred in a specific condition), and risperidone treatment produced function-specific reductions of their destructive behavior.",
author = "Zarcone, {Jennifer R.} and Lindauer, {Steven E.} and Morse, {Paige S.} and Crosland, {Kimberly A.} and Valdovinos, {Maria G.} and McKerchar, {Todd L.} and Reese, {R. Matthew} and Hellings, {Jessica A.} and Schroeder, {Stephen R.}",
year = "2004",
month = "7",
doi = "10.1352/0895-8017(2004)109<310:EORODB>2.0.CO;2",
volume = "109",
pages = "310--321",
journal = "American Journal on Intellectual and Developmental Disabilities",
issn = "1944-7515",
publisher = "American Association on Intellectual and Developmental Disabilities",
number = "4",

}

TY - JOUR

T1 - Effects of risperidone on destructive behavior of persons with developmental disabilities

T2 - American Journal on Intellectual and Developmental Disabilities

AU - Zarcone,Jennifer R.

AU - Lindauer,Steven E.

AU - Morse,Paige S.

AU - Crosland,Kimberly A.

AU - Valdovinos,Maria G.

AU - McKerchar,Todd L.

AU - Reese,R. Matthew

AU - Hellings,Jessica A.

AU - Schroeder,Stephen R.

PY - 2004/7

Y1 - 2004/7

N2 - Functional analyses were conducted during a double-blind, placebo-controlled study of the atypical antipsychotic medication risperidone with 13 individuals. Risperidone was effective in reducing destructive behavior (compared to placebo) for 10 participants. For 7 of these responders, an undifferentiated pattern of responding occurred across their baseline functional analysis conditions (i.e., a similar rate of responding across conditions), and risperidone treatment produced nonspecific reductions of their destructive behavior across functional analysis conditions. For the remaining 3 responders, a differentiated pattern of responding occurred across their baseline functional analysis conditions (i.e., an elevated rate of responding occurred in a specific condition), and risperidone treatment produced function-specific reductions of their destructive behavior.

AB - Functional analyses were conducted during a double-blind, placebo-controlled study of the atypical antipsychotic medication risperidone with 13 individuals. Risperidone was effective in reducing destructive behavior (compared to placebo) for 10 participants. For 7 of these responders, an undifferentiated pattern of responding occurred across their baseline functional analysis conditions (i.e., a similar rate of responding across conditions), and risperidone treatment produced nonspecific reductions of their destructive behavior across functional analysis conditions. For the remaining 3 responders, a differentiated pattern of responding occurred across their baseline functional analysis conditions (i.e., an elevated rate of responding occurred in a specific condition), and risperidone treatment produced function-specific reductions of their destructive behavior.

UR - http://www.scopus.com/inward/record.url?scp=5444260738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5444260738&partnerID=8YFLogxK

U2 - 10.1352/0895-8017(2004)109<310:EORODB>2.0.CO;2

DO - 10.1352/0895-8017(2004)109<310:EORODB>2.0.CO;2

M3 - Article

VL - 109

SP - 310

EP - 321

JO - American Journal on Intellectual and Developmental Disabilities

JF - American Journal on Intellectual and Developmental Disabilities

SN - 1944-7515

IS - 4

ER -